Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Ryman Healthcare (RYM) Price & Analysis

RYM Stock Chart & Stats

NZ$1.77NZ$0.03(1.72%)
At close: 4:00 PM EDT
NZD 1.8NZD 2NZD 2.23 Aug17 Aug31 Aug14 Sep28 Sep12 Oct27 Oct
Day’s Range
NZD 1.74 - NZD 1.78
52-Week Range
NZD 1.66 - NZD 3.05
Previous Close
NZD 1.74
Volume
979.70K
Average Volume (3M)
2.25M
Market Cap
NZD 1.80B
Enterprise Value
NZD 3.73B
Total Cash (Recent Filing)
NZD 9.70M
Total Debt (Recent Filing)
NZD 1.59B
Price to Earnings (P/E)
―
Beta
1.65
Next Earnings
Nov 25, 2026
EPS Estimate
0.03
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Cash Generation

The return to positive free cash flow provides internally generated funding for debt reduction, essential investment and future distributions. Because it was supported by stronger sales, lower development spending and land divestments, it marks meaningful progress in financial resilience rather than merely accounting improvement.

Aged-care Operating Momentum

Strong occupancy and rising earnings per bed indicate resilient demand for higher-acuity care and improving operating productivity. This care-led revenue base can make earnings more recurring and less dependent on retirement-unit resales, while demographic demand supports relevance over the medium term.

Balance-sheet And Capital Discipline

Lower gearing, substantial debt headroom and extended maturities improve Ryman’s ability to manage its asset-heavy model through volatility. Reducing construction activity also limits capital intensity and execution risk, allowing management to prioritise cash generation and existing-village performance.

Bears Say

Persistent Profitability Weakness

Revenue growth has not yet translated into dependable profits, leaving returns on capital weak and making future performance more sensitive to execution. Sustained operating losses can constrain reinvestment and shareholder distributions, even while reported cash flow remains positive.

Resale Stock And Margin Pressure

Higher resale inventory and softer margins tie up capital and reduce the cash generated when units turn over. Management’s target of matching sales with turnover by FY27 shows the issue remains unresolved, while competitive pricing and weaker housing conditions could prolong the pressure.

Delayed DMF Cash Benefits

The revised deferred management fee structure may strengthen economics over time, but the portfolio’s existing contracts delay recognition of those benefits. This creates a prolonged gap between strategic improvements and cash realization, limiting near-term support for earnings and financial flexibility.

Ryman Healthcare News

RYM FAQ

What was Ryman Healthcare’s price range in the past 12 months?
Ryman Healthcare lowest stock price was NZ$1.66 and its highest was NZ$3.05 in the past 12 months.
What is Ryman Healthcare’s market cap?
Ryman Healthcare’s market cap is NZ$1.80B.
When is Ryman Healthcare’s upcoming earnings report date?
Ryman Healthcare’s upcoming earnings report date is Nov 25, 2026 which is in 24 days.
How were Ryman Healthcare’s earnings last quarter?
Ryman Healthcare released its earnings results on May 25, 2026. The company reported -NZ$0.124 earnings per share for the quarter.
Is Ryman Healthcare overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Ryman Healthcare pay dividends?
Ryman Healthcare pays a Semiannually dividend of NZ$0.078 which represents an annual dividend yield of ―. See more information on Ryman Healthcare dividends here
What is Ryman Healthcare’s EPS estimate?
Ryman Healthcare’s EPS estimate is 0.03.
How many shares outstanding does Ryman Healthcare have?
Ryman Healthcare has 1,015,745,360 shares outstanding.
What happened to Ryman Healthcare’s price movement after its last earnings report?
Ryman Healthcare reported an EPS of -NZ$0.124 in its last earnings report. Following the earnings report the stock price went up 1.37%.
Which hedge fund is a major shareholder of Ryman Healthcare?
Currently, no hedge funds are holding shares in NZ:RYM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology